EquityZen Review 2026: Fees, Track Record, and Real Risk

Bottom line: EquityZen is a legitimate, SEC-registered broker-dealer marketplace that lets accredited investors buy exposure to pre-IPO companies like SpaceX, OpenAI, and Stripe through single-purpose vehicles, with minimums as low as $5,000 and transaction fees now at 2.5% (down from 5% after Morgan Stanley acquired the platform in January 2026). It works as advertised on the mechanics. What it cannot fix is the asset class itself. Your shares are locked up for years with no guaranteed exit, the price you pay is often a real premium over the company's last official valuation, and platform-reported return figures leave out the deals that never resolved. Use it as one small, speculative sleeve of a diversified portfolio, never as a core holding, and never with money you need back on a schedule.

EquityZen has built its business on solving a real problem: startup employees and early investors sit on paper wealth they cannot touch until an IPO or acquisition, sometimes for a decade or more, while accredited investors want exposure to companies like SpaceX or Databricks before they ever ring a bell on Nasdaq. Since its 2013 founding, the company says it has closed more than 49,000 private placements across nearly 500 companies, and Morgan Stanley found the model compelling enough to buy the platform outright, according to Morgan Stanley's own announcement that it closed the acquisition in January 2026. That deal is the biggest fact you need to know walking in. This is no longer a scrappy fintech startup. It is a subsidiary of one of the largest wealth managers in the country, and its fee structure changed as a result.

I am not in the business of telling you which specific security to buy. Angel Investors Network is a research and education network, not a broker-dealer, and nothing here recommends purchasing shares in any company mentioned. What follows is a plain accounting of how EquityZen works, what it has actually delivered, and where the real risk sits.

How EquityZen actually works: the SPV, the fees, and who can invest

EquityZen does not sell you stock directly in most cases. When you invest in what EquityZen calls a "Standard Deal," you buy a membership interest in a special purpose vehicle, or SPV: a Delaware LLC created solely to hold shares in one private company. EquityZen acts as managing member, the SPV becomes a single new entrant on that company's capitalization table (the official ledger of who owns what), and you own a pro-rata slice of whatever the fund holds. You do not appear on the company's books yourself. If the company eventually goes public or gets acquired, the fund distributes the underlying shares, or cash, to you after any lockup expires.

This structure exists because it is regulatorily convenient and it lowers the minimum check size. EquityZen's SPVs are typically offered under Regulation D of the Securities Act, the federal exemption that lets companies raise money privately without a full public registration. That is why participation is restricted to accredited investors: individuals who meet SEC income or net worth thresholds, or hold certain professional licenses. You can confirm the mechanics in EquityZen's own EDGAR filings. A Form D notice for one recent vehicle, EquityZen Growth Technology Fund LLC - Series 2309, shows a Delaware LLC, a total offering near $350,000, and EquityZen Securities LLC as placement agent, one of well over a thousand similar SPV notices EquityZen has filed with the SEC since 2015.

EquityZen offers four main products, and minimums and mechanics differ sharply across them.

Product	What you own	Typical minimum	Fee (buyer side, post-2026)
Standard Deal (Single Company Fund)	Membership interest in an SPV holding one company's shares	As low as $5,000 for select deals, though $10,000 to $50,000 is more typical	2.5% up to $1 million, 2.0% above
Express Deal	An existing SPV position resold by another investor	Varies, often an odd figure like $13,647 because you buy the whole resold block	Same tiered structure
Funded Vehicle (diversified fund)	Interest in a multi-company fund picked by an investment committee	Starts around $50,000, with occasional $20,000 slots	Same tiered structure, plus potential fund administration costs
Direct Share Acquisition	Shares registered in your own name on the company's cap table	Typically $150,000 and up	2.5% up to $10 million, 2.0% above

Fee-wise, the important context is the Morgan Stanley deal itself. EquityZen's own blog confirms the current structure charges 2.5% on Standard Deals up to $1 million and 2% above that on the buyer's side, with sellers paying a comparable fee. Independent platform trackers that monitor SEC filings put pre-acquisition combined friction, buyer fee plus seller fee reflected in pricing, closer to 8 to 10% on smaller deals before the February 2026 cut brought total friction to roughly 5%. Do the math before you commit. On a $50,000 Standard Deal at 2.5%, you wire $51,250, and that fee is gone regardless of performance. EquityZen does not charge an ongoing management fee or carried interest, meaning a share of profits, on single-company SPVs, unlike a traditional venture fund's "2 and 20" model. Read each deal's subscription agreement for pass-through administrative costs.

One more detail matters for eligibility: EquityZen Securities LLC, the subsidiary that executes trades, is a FINRA-registered broker-dealer, and EquityZen Advisors LLC shows up in the SEC's Investment Adviser Public Disclosure database. That is the difference between running deals through unregistered intermediaries and operating inside the regulated broker-dealer system, a real point in EquityZen's favor versus less formal secondary channels.

What EquityZen has actually offered: the track record

EquityZen's deal flow reads like a list of the most talked-about private companies of the last decade. Its own marketplace pages advertise or have previously advertised access to SpaceX, Stripe, OpenAI, ByteDance (TikTok's parent), Reddit, Epic Games, Axiom Space, and Databricks, among hundreds of others. Access to any one depends on whether a current shareholder is willing to sell and whether the company approves the transfer, so availability shifts week to week. Do not treat any company name on a marketing page as a standing guarantee of supply.

Scale-wise, the numbers are large by secondary-market standards. Following the Morgan Stanley deal, EquityZen reported more than 850,000 registered users, relationships with 450-plus private companies, roughly $1.5 billion distributed to selling shareholders, and around $710 million distributed to investors across more than 53,000 company-approved transactions, figures that appear in both EquityZen's blog materials and in Morgan Stanley's own deal announcement. A separate review of EquityZen-linked Form D filings on SEC EDGAR counted 1,890 funded SPVs raising a combined $1.484 billion across 48,614 subscription positions between 2015 and 2026, a useful independent check on the platform's self-reported scale.

EquityZen also advertises a 74% aggregate net return across its realized, exited investments. Treat that figure with real skepticism. It covers only resolved positions, excludes the unresolved portion of the portfolio entirely, and comes with no disclosed hold periods, vintage-year breakdown, or methodology for how written-off positions get counted. A 74% aggregate return sounds compelling until you realize you cannot annualize it, cannot compare it to a public benchmark, and have no way of knowing whether it reflects three winners masking forty quiet losses.

Jeff's honest risk read: illiquidity, markup, and what actually goes wrong

The mechanics of a platform and the economics of the underlying asset class are two different questions, and investors regularly confuse them. EquityZen's mechanics are clean: registered broker-dealer, standardized SPV documents, company-approved transfers. The asset class underneath is genuinely risky, and no amount of platform polish changes that.

Start with illiquidity, the risk that you cannot sell when you want. Once you invest in an EquityZen fund, your capital is locked up until the underlying company has a liquidity event: an IPO, an acquisition, or a company-run tender offer. There is no secondary market for your SPV interest itself in most cases, aside from the narrow Express Deal mechanism, which requires you to have held the position at least a year and own more than 2% of the fund before you are even eligible to list it for resale. AIN's own reporting on the broader pre-IPO secondary market documented what this looks like when it goes wrong: investors who bought Instacart shares on the secondary market at roughly $133 a share in 2021 watched the company list on Nasdaq at $30 in September 2023, a 75% loss before they could sell a single share, then sat locked up another 180 days after that. Even after a company finally goes public, standard post-IPO lockups run 90 to 180 days, during which you cannot sell regardless of where the stock trades, and lockup expiration often coincides with heavy selling pressure as every other early investor tries to exit at once.

Second, markup risk. The price you pay on EquityZen is not automatically the same as the company's most recent official valuation, and it is often higher. A private company's 409A valuation, the IRS-required appraisal used to price employee stock options, typically runs 20% to 70% below the price paid by the last institutional investor, because 409A appraisals discount for liquidation preferences that give preferred shareholders first claim on exit proceeds. Secondary prices, including EquityZen's, tend to track closer to or above the last primary funding round, and in hot markets that premium can run well into double digits. That is not automatically a red flag, since it can reflect real growth since the last round, but the burden is on you to understand why you are paying that premium rather than assume the platform has vetted it for fairness. A platform review that examined live EquityZen listings for one company in mid-2026 found eleven simultaneous listings for the identical security priced from $19 to $27 per share, all above EquityZen's own published reference price. Sellers set their own asking prices, and EquityZen does not steer you toward the cheapest one.

Third, platform and execution risk, where the user-review record gets useful despite being anecdotal. On Trustpilot, EquityZen carries roughly a 4.0-out-of-5 "Great" rating across more than 330 reviews as of early 2026, respectable, but read past the headline score. One reviewer described being told, after years of holding a position, that they were "not able to sell your investment" because EquityZen had stopped supporting secondary transactions for that company, leaving them, in their words, completely locked in. Others complained about multi-week delays receiving proceeds and difficulty getting into deals for the most in-demand names. On Reddit and the professional-network app Blind, longtime posters have been blunter. One Blind thread asked plainly whether platforms like EquityZen are a rip-off, and the top reply was simply that they are not charities. None of this makes EquityZen a scam. It makes it a business with the customer-service friction you should expect from any firm processing complex private securities transactions.

Finally, structural risk that has nothing to do with EquityZen specifically. Most pre-IPO companies never IPO on the timeline investors expect, some never IPO at all, and a company can complete a down round, meaning a new funding round priced below the last one, between the day you buy and the day it exits. Klarna's valuation collapsed from $45 billion in 2021 to $6.7 billion by mid-2022, an 85% drop in just over a year, before recovering substantially later. Anyone who bought secondary exposure near the peak sat on a paper loss for years. That is not an EquityZen-specific failure. It is what happens when you buy equity in a company with no obligation to go public on your timetable.

Who this is actually right for, and who should stay away

EquityZen makes sense for an accredited investor who already has a fully funded emergency reserve, a diversified core portfolio of public equities and fixed income, and genuinely disposable capital they can lock away for five to ten years without a second thought. If you want a small, speculative allocation to late-stage private technology names, and you accept you might get zero liquidity events and a total loss, EquityZen's registered broker-dealer status, standardized SPV paperwork, and lower 2.5% fee make it one of the more legible ways to do that compared to informal secondary channels or unregistered forward-contract brokers.

It is the wrong tool if you need your money back on a predictable schedule, if a 2.5% fee plus a multi-year hold plus a K-1 tax form (the document partnerships and LLCs issue to members, which often arrives late and complicates your filing) sounds like more friction than you want, or if you are drawn to a company name because it is famous rather than because you worked through the premium you are paying over its last valuation. If a platform's marketing page is the entirety of your due diligence, skip pre-IPO secondaries and stick to public markets or a diversified fund with professional underwriting.

Say this plainly: Angel Investors Network does not recommend that you buy shares in any specific company through EquityZen or any other platform. This article exists to help you understand how the mechanism works and where its risks sit, so you go in with eyes open, run your own numbers on the premium you would pay, and size the position like the speculative, illiquid bet that it is.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.